Artsy limited editions, unusual open-frame designs, retro throwbacks, and bold new ideas made this a standout year for the PC ...
This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock ...
Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback